Dr Lalchandani Labs Ltd vs Manipal Health Enterprises Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Dr Lalchandani Labs Ltd is ₹ 6.96 as of 23 Oct 15:30 . The P/E Ratio of Dr Lalchandani Labs Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Manipal Health Enterprises Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Dr Lalchandani Labs Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Manipal Health Enterprises Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Dr Lalchandani Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Manipal Health Enterprises Ltd for the Jun '26 is ₹ 3165 crore as compare to the Mar '26 revenue of ₹ 2917 crore. This represent the growth of 8.48% The ebitda of Dr Lalchandani Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Manipal Health Enterprises Ltd for the Jun '26 is ₹ 795.7 crore as compare to the Mar '26 ebitda of ₹ 717.81 crore. This represent the growth of 10.85% The net profit of Dr Lalchandani Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of 0.0% The net profit of Manipal Health Enterprises Ltd changed from ₹ 254.04 crore to ₹ 243.43 crore over 5 quarters. This represents a CAGR of -3.36% The Dividend Payout of Dr Lalchandani Labs Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Manipal Health Enterprises Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Dr Lalchandani Labs Ltd

Dr Lalchandani Labs Limited was originally incorporated as Partnership Firm at New Delhi dated 15 September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories.
Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited on 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017.
The Firm was established by Dr. Arjan Lal Chandani and his son Mr. Mohit Lal Chandani as a Partnership Firm in the name of 'Dr. A Lalchandani Pathology Laboratories' in 2011 and in year 2017, they formed a Company in the name and style M/s Dr Lalchandani Labs Limited and took over the Partnership firm. The Company is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through its integrated network, it offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

About Manipal Health Enterprises Ltd

Manipal Health Enterprises Limited was originally incorporated in Bengaluru, Karnataka as Manipal Health Enterprises Private Limited' as a private limited company dated February 15, 2010, issued by the RoC. Subsequently, Company was converted to a public limited company and the name was changed to Manipal Health Enterprises Limited and a fresh certificate of incorporation dated December 24, 2025 was issued by the Central Processing Centre.
The Company is engaged in the business of running/managing hospitals, and providing healthcare services.
It operates through various Hospitals/clinics providing Healthcare services and diagnostic centres, in India. The Company commenced its operations at Bengaluru, Karnataka, Near Manipal Hospital Old Airport Road in year 1991.
In 1993, it expanded presence in hospitals in Bengaluru and further to Goa in 1994, commenced operations in Mangalore at KMC Hospital in 1997.

FAQs for the comparison of Dr Lalchandani Labs Ltd and Manipal Health Enterprises Ltd

Which company has a larger market capitalization, Dr Lalchandani Labs Ltd or Manipal Health Enterprises Ltd?

Market cap of Dr Lalchandani Labs Ltd is 6 Cr while Market cap of Manipal Health Enterprises Ltd is 79,830 Cr

What are the key factors driving the stock performance of Dr Lalchandani Labs Ltd and Manipal Health Enterprises Ltd?

The stock performance of Dr Lalchandani Labs Ltd and Manipal Health Enterprises Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Lalchandani Labs Ltd and Manipal Health Enterprises Ltd?

As of October 25, 2026, the Dr Lalchandani Labs Ltd stock price is INR ₹6.96. On the other hand, Manipal Health Enterprises Ltd stock price is INR ₹606.9.

How do dividend payouts of Dr Lalchandani Labs Ltd and Manipal Health Enterprises Ltd compare?

To compare the dividend payouts of Dr Lalchandani Labs Ltd and Manipal Health Enterprises Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.